Taipei Exchange - Delayed Quote TWD

Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO)

Compare
76.10
+5.60
+(7.94%)
At close: January 22 at 2:59:58 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
728.00
728.00
2,697.00
88.00
73.00
Cost of Revenue
399.00
399.00
1,405.00
41.00
2.00
Gross Profit
329.00
329.00
1,292.00
47.00
71.00
Operating Expense
60,235.00
60,235.00
44,663.00
28,352.00
18,075.00
Operating Income
-59,906.00
-59,906.00
-43,371.00
-28,305.00
-18,004.00
Net Non Operating Interest Income Expense
1,753.00
1,753.00
1,239.00
691.00
92.00
Pretax Income
-56,791.00
-56,791.00
-39,807.00
-27,306.00
-17,453.00
Tax Provision
-5,009.00
-5,009.00
-8,070.00
-4,955.00
-3,483.00
Net Income Common Stockholders
-51,782.00
-51,782.00
-31,737.00
-22,351.00
-13,970.00
Diluted NI Available to Com Stockholders
-51,782.00
-51,782.00
-31,737.00
-22,351.00
-13,970.00
Basic EPS
-2.07
--
-1.27
-1.19
-1.64
Diluted EPS
-2.07
--
-1.27
-1.19
-1.64
Basic Average Shares
25,027.47
--
25,027.47
18,863.70
8,527.65
Diluted Average Shares
26,535.12
--
25,027.47
18,863.70
8,527.65
Total Expenses
60,634.00
60,634.00
46,068.00
28,393.00
18,077.00
Net Income from Continuing & Discontinued Operation
-51,782.00
-51,782.00
-31,737.00
-22,351.00
-13,970.00
Normalized Income
-51,782.00
-51,782.00
-31,737.00
-22,351.00
-13,970.00
Interest Income
1,795.00
1,795.00
1,321.00
780.00
161.00
Interest Expense
42.00
42.00
82.00
89.00
69.00
Net Interest Income
1,753.00
1,753.00
1,239.00
691.00
92.00
EBIT
-56,749.00
-56,749.00
-39,725.00
-27,217.00
-17,384.00
EBITDA
-46,244.00
-46,244.00
-30,174.00
-19,617.00
-11,335.00
Reconciled Cost of Revenue
399.00
399.00
1,405.00
41.00
2.00
Reconciled Depreciation
10,505.00
10,505.00
9,551.00
7,600.00
6,049.00
Net Income from Continuing Operation Net Minority Interest
-51,782.00
-51,782.00
-31,737.00
-22,351.00
-13,970.00
Normalized EBITDA
-46,244.00
-46,244.00
-30,174.00
-19,617.00
-11,335.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 12/29/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

7814.TWO HORIEN
29.95
-4.92%
 
6872.TWO NaviFUS Corp.
28.00
+3.13%
 
7808.TWO BIONET TX Corp
46.00
-0.33%
 
7754.TWO AnnJi
32.55
0.00%
 
7427.TWO Great Novel Therapeutics Biotech & Medicals
32.70
-1.36%
 
7790.TWO SSLab
77.50
+3.47%
 
4197.TWO Visgeneer Inc.
11.10
+13.50%
 
6748.TWO ACRO Biomedical Co., Ltd.
23.40
0.00%
 
6973.TWO U-Neuron Biomedical Inc
39.05
+1.69%
 
6580.TWO TaiRx, Inc.
26.35
-0.38%